Liaison anti-HBc - Hepatitis B virus core total antibody IVD, kit, chemiluminescent immunoassay

Intended purpose

For the qualitative determination of total antibodies to hepatitis B core antigen (anti-HBc) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).

Functional description

The LIAISON® Anti-HBc assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of total antibodies to hepatitis B core antigen (anti-HBc) in human serum or plasma samples.